{"title":"Association between premature vascular smooth muscle cells senescence and vascular inflammation in Takayasu's arteritis.","authors":"Chenglong Fang, Lihong Du, Shang Gao, Yuexin Chen, Zuoguan Chen, Zhiyuan Wu, Lili Li, Jing Li, Xiaofeng Zeng, Mengtao Li, Yongjun Li, Xinping Tian","doi":"10.1136/ard-2024-225630","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Arterial wall inflammation and remodelling are the characteristic features of Takayasu's arteritis (TAK). It has been proposed that vascular smooth muscle cells (VSMCs) are the main targeted cells of inflammatory damage and participate in arterial remodelling in TAK. Whether VSMCs are actively involved in arterial wall inflammation has not been elucidated. Studies have shown that cellular senescence in tissue is closely related to local inflammation persistence. We aimed to investigate whether VSMCs senescence contributes to vascular inflammation and the prosenescent factors in TAK.</p><p><strong>Methods: </strong>VSMCs senescence and senescence-associated secretory phenotype were detected by histological examination, bulk RNA-Seq and single-cell RNA-seq conducted on vascular surgery samples of TAK patients. The key prosenescent factors and the downstream signalling pathway were investigated in a series of in vitro and ex vivo experiments.</p><p><strong>Results: </strong>Histological findings, primary cell culture and transcriptomic analyses demonstrated that VSMCs of TAK patients had the features of premature senescence and contributed substantially to vascular inflammation by upregulating the expression of senescence-associated inflammatory cytokines. IL-6 was found to be the critical cytokine that drove VSMCs senescence and senescence-associated mitochondrial dysfunction in TAK. Mechanistically, IL-6-induced non-canonical mitochondrial localisation of phosphorylated STAT3 (Tyr705) prevented mitofusin 2 (MFN2) from proteasomal degradation, and subsequently promoted senescence-associated mitochondrial dysfunction and VSMCs senescence. Mitochondrial STAT3 or MFN2 inhibition ameliorated VSMCs senescence in ex vivo cultured arteries of TAK patients.</p><p><strong>Conclusions: </strong>VSMCs present features of cellular senescence and are actively involved in vascular inflammation in TAK. Vascular IL-6-mitochondrial STAT3-MFN2 signalling is an important driver of VSMCs senescence.</p>","PeriodicalId":8087,"journal":{"name":"Annals of the Rheumatic Diseases","volume":" ","pages":"1522-1535"},"PeriodicalIF":20.3000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11503059/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of the Rheumatic Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/ard-2024-225630","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Arterial wall inflammation and remodelling are the characteristic features of Takayasu's arteritis (TAK). It has been proposed that vascular smooth muscle cells (VSMCs) are the main targeted cells of inflammatory damage and participate in arterial remodelling in TAK. Whether VSMCs are actively involved in arterial wall inflammation has not been elucidated. Studies have shown that cellular senescence in tissue is closely related to local inflammation persistence. We aimed to investigate whether VSMCs senescence contributes to vascular inflammation and the prosenescent factors in TAK.
Methods: VSMCs senescence and senescence-associated secretory phenotype were detected by histological examination, bulk RNA-Seq and single-cell RNA-seq conducted on vascular surgery samples of TAK patients. The key prosenescent factors and the downstream signalling pathway were investigated in a series of in vitro and ex vivo experiments.
Results: Histological findings, primary cell culture and transcriptomic analyses demonstrated that VSMCs of TAK patients had the features of premature senescence and contributed substantially to vascular inflammation by upregulating the expression of senescence-associated inflammatory cytokines. IL-6 was found to be the critical cytokine that drove VSMCs senescence and senescence-associated mitochondrial dysfunction in TAK. Mechanistically, IL-6-induced non-canonical mitochondrial localisation of phosphorylated STAT3 (Tyr705) prevented mitofusin 2 (MFN2) from proteasomal degradation, and subsequently promoted senescence-associated mitochondrial dysfunction and VSMCs senescence. Mitochondrial STAT3 or MFN2 inhibition ameliorated VSMCs senescence in ex vivo cultured arteries of TAK patients.
Conclusions: VSMCs present features of cellular senescence and are actively involved in vascular inflammation in TAK. Vascular IL-6-mitochondrial STAT3-MFN2 signalling is an important driver of VSMCs senescence.
目的:动脉壁炎症和重塑是高安氏动脉炎(TAK)的特征。有人认为,血管平滑肌细胞(VSMC)是炎症损伤的主要靶细胞,并参与了 TAK 的动脉重塑。血管平滑肌细胞是否积极参与了动脉壁炎症尚未得到阐明。研究表明,组织中的细胞衰老与局部炎症的持续存在密切相关。我们旨在研究 VSMCs 衰老是否导致血管炎症以及 TAK 中的前衰老因子:方法:通过组织学检查、大样本RNA-Seq和单细胞RNA-Seq检测TAK患者血管手术样本中的VSMCs衰老和衰老相关分泌表型。在一系列体外和体内实验中研究了关键的前衰老因子及其下游信号通路:组织学发现、原代细胞培养和转录组分析表明,TAK 患者的血管内皮细胞具有早衰特征,并通过上调与衰老相关的炎性细胞因子的表达,在很大程度上导致了血管炎症。研究发现,IL-6是促使TAK患者VSMC衰老和衰老相关线粒体功能障碍的关键细胞因子。从机理上讲,IL-6诱导的磷酸化STAT3(Tyr705)的非典型线粒体定位阻止了丝裂霉素2(MFN2)的蛋白酶体降解,进而促进了衰老相关的线粒体功能障碍和VSMCs衰老。抑制线粒体STAT3或MFN2可改善TAK患者体外培养动脉中VSMCs的衰老:结论:VSMCs呈现出细胞衰老的特征,并积极参与TAK患者的血管炎症。血管IL-6-线粒体STAT3-MFN2信号是VSMC衰老的重要驱动因素。
期刊介绍:
Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.